New epicGEN Solid Cancer & MSI Kit provides a powerful next-generation sequencing (NGS) solution designed to meet the growing demands of oncological research and diagnostics.
Our integrated approach combines efficient library preparation and data analysis to deliver accurate results.

Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.

Due to its high sensitivity (as low as 1 ng of input DNA), the kit is also suitable for low-content and degraded samples such as cfDNA or FFPE tissues, allowing accurate detection of somatic mutations with VAF >1% at sufficient sequencing depth (~500× or more).

Optimized protocols ensure reliable results and flexibility for a wide range of research and clinical applications.  

epicGEN is a technology for high-precision mutation analysis of oncogenic and hereditary markers in clinical samples.

The technology is based on ultra-deep sequencing of selectively enriched genomic regions, utilizing an optimized hybrid capture system to ensure maximum specificity, sensitivity, and uniform coverage.

Highly specific oligonucleotides precisely target desired sequences, minimizing non-specific enrichment and improving coverage.

Minimizes off-target binding, reducing interference from non-coding and repetitive genomic regions for greater precision.

Detects somatic mutations at VAF >1% with sufficient sequencing depth (~500×), ensuring high sensitivity in mutation analysis.

• • • User-friendliness
    • Automatized bioinformatic analysis
    • Advanced quality control of sequencing data
    • Easy variants filtration
    • Local clinical variants database
    • Visualization of NGS data
    • Internal interpretation of variants and sharing between clinics
    • Clinical report generation
    • Custom baseline creation